malignant and benign mediastinal hilar lymphadenopathy.
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients with hilar and mediastinal lymphadenopathy. 20 years old and above
Exclusion criteria
Exclusion criteria: Patients who are considered as inappropriate by physician. Rebiopsy to detect resistance mutation
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Comparison of the diagnostic yield between 22-gauge and 25-gauge needles for endobronchial ultrasound-guided transbronchial needle aspiration. | — |
Secondary
| Measure | Time frame |
|---|---|
| Comparison of the diagnostic yield based on malignant and benign regions, histological diagnostic yield and cytological diagnostic yield, quantity of histological core tissue, maneuverability, safety | — |
Countries
Japan
Contacts
Matsusaka Municipal Hospital Department of respiratory medicine